Endothelin-1 and Accelerated Cardiac Allograft Vasculopathy After Heart Transplantation
- PMID: 40607852
- DOI: 10.1161/CIRCHEARTFAILURE.125.013288
Endothelin-1 and Accelerated Cardiac Allograft Vasculopathy After Heart Transplantation
Keywords: coronary artery disease; endothelin-1; heart transplantation.
Conflict of interest statement
Dr Parikh receives research support from Abbott Vascular, Bayer, and Infraredx (Nipro) and consulting fees from Abbott Vascular, CathWorks, and Nipro. Dr Fearon receives institutional research support from Abbott Vascular, CathWorks, and Medtronic, consults with ShockWave, and holds stock in HeartFlow. Dr Khush reports consulting for CareDx, Eledon Pharmaceuticals, and Sanofi. Dr Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Eli Lilly, Johnson & Johnson, Medtronic, Merck, Novartis, and Pfizer. The other authors report no conflicts.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources